Admedus herpes vaccine trial achieves endpoint
Vaccines | News | By BioSpectrum Bureau | 1 Comment | 03 Feb, 2014
Singapore: Australian firm, Admedus, has achieved positive endpoint in its phase I trial of a therapeutic vaccine for H...Read more
Teva suspects foriegn material in Adrucil injection
Vaccines | Regulatory | By BioSpectrum Bureau | 2 Comment | 06 May, 2015
Singapore: Teva Parenteral Medicines has issued a voluntary recall of eight lots of Adrucil (fluorouracil injection) due...Read more
Pevion Biotech to manufacture HER-Vaxx
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2013
Singapore: Biolife Science has signed a letter of intent with Swiss company Pevion Biotech for the manufacture of Biolif...Read more
China firm develops new therapeutic vaccine for rabies
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Mar, 2015
Singapore: China's Yisheng Biopharma, a biopharmaceutical company developing vaccines, has developed a new vaccine for t...Read more
Hospira recalls Lidocaine HCI Injection for containing unwanted particles
Vaccines | Regulatory | By BioSpectrum Bureau | 2 Comment | 30 Jul, 2014
Singapore: Global biopharmaceutical company, Hospira, has initiated recall of one lot of Lidocaine HCI Injection, USP, 2...Read more
Dengvaxia, world's first dengue vaccine approved in Mexico
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2015
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has announced that the Mexican authorities have granted mark...Read more
Quality issues get Novartis vaccine in trouble in EU
Vaccines | Regulatory | By BioSpectrum Bureau | 2 Comment | 29 Oct, 2012
Singapore: A number of European Union (EU) member states have halted the use, as a precautionary measure, of some anti-i...Read more
Ebola vaccine developer turns to crowdfunding to raise money for R&D
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2014
Singapore: Pentamer Pharmaceuticals, US based biopharmaceutical company that has developed an ebola vaccine candidate, i...Read more
PharmaJet, CSL to make needle free flu vaccines
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
Singapore: US-based PharmaJet entered into a collaboration with CSL to enable Afluria influenza vaccine to be delivered...Read more
China journeys from imitation to innovation
Vaccines | Analysis | By BioSpectrum Bureau | 2 Comment | 23 May, 2012
With a population of over 1.3 billion, China is poised for continued growth in the life sciences sector. There are sever...Read more
Allied Healthcare cancer vaccine study is a success
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 16 Nov, 2012
Singapore: Australian biomedical company, Allied Healthcare, achieved successful results of its initial study of a novel...Read more
Korea to nurture its vaccine makers
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 27 Jan, 2015
Singapore: The Korean Ministry of Food and Drug Safety (MFDS) recently announced plans to support and nurture domestic v...Read more
New vulnerable site on HIV discovered
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2014
Singapore: Scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) ha...Read more
Australia worried about low child immunization rates
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013
Singapore: National Health Performance Authority in Australia has revealed that while Australia has high immunization ra...Read more
Hope floats for neglected tropical diseases
Vaccines | Analysis | By BioSpectrum Bureau | 2 Comment | 22 Jun, 2012
The first-of-its-kind clinical trial to test the efficacy of a novel visceral leishmaniasis vaccine has started in India...Read more
Sanofi Pasteur to pioneer Zika Vaccine R&D
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2016
World's leading vaccine maker Sanofi Pasteur has launched a vaccine research and development project targeting the preve...Read more
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2012
Singapore: BD (Becton, Dickinson and Company), a leading global medical technology company, has entered into a definitiv...Read more
GSK, Biological E to develop 6-in-1 vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Bangalore: GlaxoSmithKline (GSK) and Biological E have signed an agreement to form a 50:50 joint venture (JV) for early ...Read more